Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline CEO: Drug pricing needs to change

Sir Andrew Witty tells CNNMoney's Cristina Alesci about the challenges surrounding the pharmaceutical space and why we need more drug pricing transparency in the U.S.